1
|
New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation. Molecules 2021; 26:molecules26040867. [PMID: 33562106 PMCID: PMC7914722 DOI: 10.3390/molecules26040867] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2021] [Revised: 01/21/2021] [Accepted: 02/03/2021] [Indexed: 11/17/2022] Open
Abstract
Proviral integration site for Moloney murine leukemia virus (Pim)-1/2 kinase overexpression has been identified in a variety of hematologic (e.g., multiple myeloma or acute myeloid leukemia (AML)) and solid (e.g., colorectal carcinoma) tumors, playing a key role in cancer progression, metastasis, and drug resistance, and is linked to poor prognosis. These kinases are thus considered interesting targets in oncology. We report herein the design, synthesis, structure–activity relationships (SAR) and in vitro evaluations of new quinoxaline derivatives, acting as dual Pim1/2 inhibitors. Two lead compounds (5c and 5e) were then identified, as potent submicromolar Pim-1 and Pim-2 inhibitors. These molecules were also able to inhibit the growth of the two human cell lines, MV4-11 (AML) and HCT-116 (colorectal carcinoma), expressing high endogenous levels of Pim-1/2 kinases.
Collapse
|
2
|
Sukanya P, Venkata Ramana Reddy C. Synthesis, characterization and in vitro anticancer, DNA binding and cleavage studies of Mn (II), Co (II), Ni (II) and Cu (II) complexes of Schiff base ligand 3-(2-(1-(1H-benzimidazol-2-yl)ethylidene)hydrazinyl)quinoxalin-2(1H)-one and crystal structure o. Appl Organomet Chem 2018. [DOI: 10.1002/aoc.4526] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Panaganti Sukanya
- Department of Chemistry; Jawaharlal Nehru Technological University Hyderabad; Hyderabad India
| | | |
Collapse
|
3
|
Microwave-assisted facile construction of quinoxalinone and benzimidazopyrazinone derivatives via two paths of post-Ugi cascade reaction. Mol Divers 2018; 23:137-145. [PMID: 30073609 DOI: 10.1007/s11030-018-9855-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2018] [Accepted: 06/25/2018] [Indexed: 10/28/2022]
Abstract
A facile and efficient route to synthesize quinoxalinone and benzimidazopyrazinone was developed via two paths of a post-Ugi cascade reaction. By simply alternating the order of nucleophilic substitution reactions, both heterocycles could be accessed selectively from the same Ugi adduct. Microwave-assisted synthesis protocol provided these compounds with one purification procedure for three steps. These two scaffolds with more possible spaces for further modifications provide great benefit toward combinatorial and medicinal chemistry campaigns.
Collapse
|
4
|
Rajamanickam G, Selvaraj J, Selvaraj S, Rajendran T. A facile synthesis and neuroprotective role of novel quinoxaline-2,3-bis hydrazones in ethidium bromide-induced demyelinated rats. Med Chem Res 2016. [DOI: 10.1007/s00044-016-1572-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
5
|
Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists. Bioorg Med Chem 2015; 23:1788-99. [PMID: 25792143 DOI: 10.1016/j.bmc.2015.02.033] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2014] [Revised: 02/16/2015] [Accepted: 02/17/2015] [Indexed: 11/23/2022]
Abstract
As part of a program aimed at discovering orally active 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonists, we screened our compound library and identified 2-[allyl(4-methylphenyl)amino]-4H-pyrido[3,2-e][1,3]thiazin-4-one (7) as a lead compound that inhibited kainate-induced neurotoxicity mediated by AMPA receptors in rat hippocampal cultures. Structure-activity relationship studies of a series of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives revealed that substituents on the phenyl ring attached to the 2-amino group and the 4H-pyrido[3,2-e][1,3]thiazin-4-one ring system play an important role in inhibitory activity against kainate-induced neurotoxicity. Several analogs bearing a phenyl group with a 4-substituent or five- or six-membered ring fused at the 3,4-positions exhibited potent inhibitory activity against kainate-induced neurotoxicity. Further, some of these compounds exhibited significant suppression of maximal electroshock seizure in mice following oral administration. Of these compounds, 2-[(4-chlorophenyl)(methyl)amino]-4H-pyrido[3,2-e][1,3]thiazin-4-one (16i) (YM928) demonstrated the most potent inhibitory effect with an ED50 value of 7.4mg/kg.
Collapse
|
6
|
Cushing TD, Hao X, Shin Y, Andrews K, Brown M, Cardozo M, Chen Y, Duquette J, Fisher B, Gonzalez-Lopez de Turiso F, He X, Henne KR, Hu YL, Hungate R, Johnson MG, Kelly RC, Lucas B, McCarter JD, McGee LR, Medina JC, San Miguel T, Mohn D, Pattaropong V, Pettus LH, Reichelt A, Rzasa RM, Seganish J, Tasker AS, Wahl RC, Wannberg S, Whittington DA, Whoriskey J, Yu G, Zalameda L, Zhang D, Metz DP. Discovery and in Vivo Evaluation of (S)-N-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease. J Med Chem 2014; 58:480-511. [DOI: 10.1021/jm501624r] [Citation(s) in RCA: 65] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Douglas A. Whittington
- Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States
| | | | | | | | | | | |
Collapse
|
7
|
Sakhuja R, Shakoor SMA, Kumari S, Kumar A. Microwave-Assisted Expedite Synthesis of 2-Phenylimidazo[1,2-a]pyridylquinoxalin-2(1H)-ones. J Heterocycl Chem 2014. [DOI: 10.1002/jhet.2189] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Rajeev Sakhuja
- Department of Chemistry; Birla Institute of Technology and Science; Pilani 333 031 Rajasthan India
| | - S. M. Abdul Shakoor
- Department of Chemistry; Birla Institute of Technology and Science; Pilani 333 031 Rajasthan India
| | - Santosh Kumari
- Department of Chemistry; Birla Institute of Technology and Science; Pilani 333 031 Rajasthan India
| | - Anil Kumar
- Department of Chemistry; Birla Institute of Technology and Science; Pilani 333 031 Rajasthan India
| |
Collapse
|
8
|
Azam F, Abugrain IM, Sanalla MH, Elnaas RF, Rajab IAI. in Silico investigation of the structural requirements for the AMPA receptor antagonism by quinoxaline derivatives. Bioinformation 2013; 9:864-9. [PMID: 24250113 PMCID: PMC3819572 DOI: 10.6026/97320630009864] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2013] [Accepted: 10/01/2013] [Indexed: 12/12/2022] Open
Abstract
Glutamate receptors have been implicated in various neurological disorders and their antagonism offers a suitable approach for the
treatment of such disorders. The field of drug design and discovery aims to find best medicines to prevent, treat and cure diseases
quickly and efficiently. In this regard, computational tools have helped medicinal chemists modify and optimize molecules to
potent drug candidates with better pharmacokinetic profiles, and guiding biologists and pharmacologists to explore new disease
genes as well as novel drug targets. In the present study, to understand the structural requirements for AMPA receptor
antagonism, molecular docking study was performed on 41 structurally diverse antagonists based on quinoxaline nucleus.
Lamarckian genetic algorithm methodology was employed for docking simulations using AutoDock 4.2 program. The results
obtained signify that the molecular docking approach is reliable and produces a good correlation coefficient (r2 = 0.6) between
experimental and docking predicted AMPA receptor antagonistic activity. The aromatic moiety of quinoxaline core has been
proved to be vital for hydrophobic contacts exhibiting - interactions in docked conformations. However, polar moieties such as
carboxylic group and 1,2,4-triazole moieties were noted to be sites for hydrophilic interactions in terms of hydrogen bonding with
the receptor. These analyses can be exploited to design and develop novel AMPA receptor antagonists for the treatment of
different neurological disorders.
Collapse
Affiliation(s)
- Faizul Azam
- Faculty of Pharmacy, Misurata University, PO Box 2873, Misurata, Libya
| | | | | | | | | |
Collapse
|
9
|
Gunawan S, Nichol G, Hulme C. Concise route to a series of novel 3-(tetrazol-5-yl)quinoxalin-2(1H)-ones. Tetrahedron Lett 2012; 53:1664-1667. [PMID: 22707799 PMCID: PMC3374393 DOI: 10.1016/j.tetlet.2012.01.080] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
Abstract
This report presents a novel three step solution phase protocol to synthesize 3-(tetrazol-5-yl)quinoxalin-2(1H)-ones. The strategy utilizes ethyl glyoxalate and mono-N-Boc-protected-o-phenylenediamine derivatives in the Ugi-Azide multi-component reaction (MCR) to generate a unique 1,5-disubstituted tetrazole. Subsequent acid treatment stimulates a simultaneous Boc deprotection and intramolecular cyclization leading to bis-3,4-dihydroquinoxalinone tetrazoles. Direct oxidation using a stable solid-phase radical catalyst (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO) with ceric ammonium nitrate (CAN) in catalytic fashion initiating aerobic oxidation, completes the entire procedure to generate a series of original unique bis-quinoxalinone tetrazoles. The method was also expanded to produce a bis-benzodiazepine tetrazole.
Collapse
Affiliation(s)
- Steven Gunawan
- BIO5 Oro Valley, The University of Arizona, 1580 E. Hanley Blvd., Oro Valley, AZ 85737
| | - Gary Nichol
- Department of Chemistry and Biochemistry, The University of Arizona, 1306 E. University Blvd., Tucson, AZ 85721
| | - Christopher Hulme
- BIO5 Oro Valley, The University of Arizona, 1580 E. Hanley Blvd., Oro Valley, AZ 85737
| |
Collapse
|
10
|
Jubie S, Gayathri R, Kalirajan R. Synthesis and Neuropharmacological Evaluation of Some Novel Quinoxaline 2, 3-Dione Derivatives. ScientificWorldJournal 2012; 2012:718023. [PMID: 22649314 PMCID: PMC3354656 DOI: 10.1100/2012/718023] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2011] [Accepted: 12/13/2011] [Indexed: 11/21/2022] Open
Abstract
Quinoxaline-2, 3-dione obtained from cyclocondensation reaction of o-phenylene diamine with oxalic acid was reacted with three different ketones and formaldehyde to give the corresponding Mannich bases in satisfactory yield. Their structures were confirmed by using 1H NMR, IR, and mass analysis. In pharmacological evaluation, the synthesized compounds showed its curative effect against ethidium-bromide-induced demyelination in rats. For the purpose, different screening methods such as open field exploratory behavior test, rota rod test, grip strength test, beam walk test, and photo actometer test were performed. Ethidium bromide induction showed muscle weakness; muscle discoordination; loss of locomotor activity, and so forth, the synthesized drugs reversed all the above-mentioned neuromuscular disorders caused by ethidium bromide administration.
Collapse
Affiliation(s)
- Selvaraj Jubie
- Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Off Campus, JSS University, Mysore 570015, India
- Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Rocklands, Ooty 643001, India
| | - Rajamanickam Gayathri
- Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Off Campus, JSS University, Mysore 570015, India
| | - Rajagopal Kalirajan
- Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Off Campus, JSS University, Mysore 570015, India
| |
Collapse
|
11
|
Kadieva MG, Oganesyan ÉT, Zefirova OH. Antagonists of AMPA/KA and NMDA (glycine site) glutamate receptors. Pharm Chem J 2008. [DOI: 10.1007/s11094-008-0063-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|